Skip to main content
Premium Trial:

Request an Annual Quote

Maravai LifeSciences Completes $50M Debt Financing

NEW YORK (GenomeWeb) – Maravai LifeSciences said today that it has completed a new debt financing that will lower the interest rate on its existing debt and provide the company with an additional $50 million in capital.

Maravai, based in San Diego, said it will use the new funds to support growth in its three life science segments: bioprocess impurity testing, oligonucleotide synthesis, and protein detection.

JP Morgan led the debt financing along with Antares Capital and Carlyle Global Credit.

Maravai portfolio companies include Vector Laboratories, which develops reagents for protein labeling and detection; Cygnus Technologies, which provides products for detecting impurities in biotherapeutic development; TriLink Biotechnologies, which provides highly modified nucleic acids for cellular and molecular biology; and Glen Research, which sells reagents to produce DNA and RNA oligonucleotides.

The Scan

Study Points to Tuberculosis Protection by Gaucher Disease Mutation

A mutation linked to Gaucher disease in the Ashkenazi Jewish population appears to boost Mycobacterium tuberculosis resistance in a zebrafish model of the lysosomal storage condition, a new PNAS study finds.

SpliceVault Portal Provides Look at RNA Splicing Changes Linked to Genetic Variants

The portal, described in Nature Genetics, houses variant-related messenger RNA splicing insights drawn from RNA sequencing data in nearly 335,700 samples — a set known as the 300K-RNA resource.

Automated Sequencing Pipeline Appears to Allow Rapid SARS-CoV-2 Lineage Detection in Nevada Study

Researchers in the Journal of Molecular Diagnostics describe and assess a Clear Labs Dx automated workflow, sequencing, and bioinformatic analysis method for quickly identifying SARS-CoV-2 lineages.

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.